Results 131 to 140 of about 54,328 (210)

Long‐duration effect and the postsynaptic compartment: Study using a dopamine agonist with a short half‐life [PDF]

, 2001
Fabrizio Stocchi, Laura Vacca, Alfredo Berardelli, Francesca De Pandis, Stefano Ruggieri   +4 more
openalex   +1 more source

Dopamine Agonists as a Novel "Cure" for Autoimmune Diabetes. [PDF]

JCEM Case Rep
Sahota S, Cooper L, Sirkova A, Stojanovic N.   +3 more
europepmc   +1 more source

Studying the suitability of hybrid micelle liquid chromatography for estimating the lipophilicity of some partial dopamine agonists used to attain the reward circuit. [PDF]

R Soc Open Sci, 2021
Wahba MEK, El Wasseef D, El Sherbiny D.
europepmc   +1 more source

Effects of the dopamine D2 agonist, quinpirole, on time and number processing in rats [PDF]

, 2001
Angelo Santi, Romina Coppa, Lori E. Ross
openalex   +1 more source

Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice [PDF]

, 2002
Rebecca J. Ralph-Williams, Virginia Lehmann-Masten, Veronica Otero-Corchón, Malcolm J. Low, Mark A. Geyer   +4 more
openalex   +1 more source

Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight. [PDF]

BMC Endocr Disord
Caprio S, Pilli T, Cantara S, Sestini F, Fioravanti C, Ciuoli C, Dalmiglio C, Corbo A, Castagna MG.   +8 more
europepmc   +1 more source

DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease. [PDF]

Ann Clin Transl Neurol
Torres V, Pérez-Montesino J, Fernández-Santiago R, Fernández M, Camara A, Compta Y, Martí MJ, Guerra Beltran À, Rios J, Valldeoriola F, Ezquerra M.   +10 more
europepmc   +1 more source

Comparative Efficacy and Safety of Dopamine Agonists in Advanced Parkinson's Disease With Motor Fluctuations: A Systematic Review and Network Meta-Analysis of Double-Blind Randomized Controlled Trials. [PDF]

Front Neurosci, 2021
Ruan X, Lin F, Wu D, Chen L, Weng H, Yu J, Wang Y, Chen Y, Chen X, Ye Q, Meng F, Cai G.   +11 more
europepmc   +1 more source

Distinct Residues in the Carboxyl Tail Mediate Agonist-induced Desensitization and Internalization of the Human Dopamine D1 Receptor [PDF]

, 2002
Michael Lamey, Miles D. Thompson, George Varghese, Hong Chi, Marek Sawzdargo, Susan R. George, Brian F. O’Dowd   +6 more
openalex   +1 more source

Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease. [PDF]

Brain Sci
Crispo JAG, Farhat N, Fortin Y, Perez-Lloret S, Sikora L, Morgan RL, Habash M, Gogna P, Kelly SE, Elliott J, Kohen DE, Bjerre LM, Mattison DR, Hessian RC, Willis AW, Krewski D.   +15 more
europepmc   +1 more source